DIFF Subgroup
C12N 15/84 Ti-plasmids
Introduced: January 1990
Full Title
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor > Recombinant DNA-technology > Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression > Vectors or expression systems specially adapted for eukaryotic hosts > for plant cells > Ti-plasmids
Top Applicants
Top Applicants (IPC)
Class C12,2013–2023, worldwide · Source: EPO PATSTAT
- CHINESE ACADEMY OF SCIENCES 10,330
- HARVARD UNIVERSITY US 7,308
- UNIVERSITY OF CALIFORNIA US 6,383
- JIANGNAN UNIVERSITY 5,144
- MONSANTO TECHNOLOGY US 4,121
- PIONEER HI-BRED INTERNATIONAL US 3,630
- REGENERON PHARMACEUTICALS US 3,515
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 3,499
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 3,371
- CJ CHEILJEDANG CORPORATION KR 3,361
Top Applicants (CPC)
Class C12,2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692